国产AV偷闻女邻居内裤被发现,国产AV高清和老师偷尝禁果,国产麻豆放荡AV剧情演绎

<dl id="7zbx1"></dl>

<div id="7zbx1"><span id="7zbx1"><ruby id="7zbx1"></ruby></span></div>

      <dl id="7zbx1"><ol id="7zbx1"><mark id="7zbx1"></mark></ol></dl>

      Events

      • 2018

        March 2018  "Pre-clinical study on EH, a new anticoagulant drug with low bleeding" was listed in the municipal "major new drug innovation" special project of Beijing municipal commission of science and technology and was funded by Beijing municipal finance. 

         

        June 2018 The clinical trial application of "Dental pulp stem cell injection" was officially undertaken by the CDE of the state administration of food and drug administration.

         

        July 2018 The company's clinical research project of "Dental umbilical cord mesenchymal stem cell injection" for the treatment of periodontitis was funded by the Beijing municipal commission of science and technology's "capital clinical characteristic application research" project.

         

        November 2018 "Clinical research on EH, a new anticoagulant drug with low bleeding" was listed in the "major new drug innovation" special project jointly organized by the ministry of science and technology and the ministry of health and won the national scientific research funding.

      • 2017

        The clinical trial application of "Dental pulp stem cell injection" for the treatment of periodontitis and the promotion of tooth tissue regeneration was submitted to Beijing municipal food and drug administration and was officially accepted. 

      • 2016

        "Recombinant hirudin for injection" has obtained SFDA approval, and can be used for continuous clinical trials from phase I to III; Phase I clinical trials were under way at you 'an hospital in Beijing.

      • 2014

        The company won the title of "Zhongguancun High-Tech Enterprise".

      • 2013

        The clinical trial application of "Recombinant hirudin for injection", a new class of anticoagulant drug, was accepted by SFDA.

      • 2012

        "Pre-clinical study on EH, a new anticoagulant drug with low bleeding" was listed in the "major new drug innovation" special project jointly organized by the ministry of science and technology and the ministry of health, and won the national scientific research funding.

      • 2011

        Beijing SH biotechnology Co., Ltd. was established in Zhongguanchun Fengtai Science Park, Beijing.

         

        A cooperation agreement on "Treatment of periodontal disease with dental stem cells" was signed with Beijing Stomatological Hospital affiliated to Capital Medical University.

      国产AV偷闻女邻居内裤被发现,国产AV高清和老师偷尝禁果,国产麻豆放荡AV剧情演绎